University of Minnesota

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).

966 total trials 180 currently recruiting 671 completed early-phase tilt top decile by trial count

University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.

University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.

Top-decile sponsor footprint

University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

966 total, page 13 of 20

COMPLETED

Correlation Analysis Between Brain Lesions and Sensorimotor Impairments in Individuals With Stroke (Preliminary Study)

NCT02465281

COMPLETED NA

Effects of Juice on Gastrointestinal Tolerance and Breath Hydrogen Response in Human Subjects

NCT02565472

COMPLETED NA

Robot-aided Proprioceptive Rehabilitation Training

NCT02565407

COMPLETED NA

Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and Mechanisms

NCT02611206

TERMINATED

Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers

NCT02529696

COMPLETED NA

Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia

NCT02226796

TERMINATED NA

Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft

NCT02551783

COMPLETED Phase 2

Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

NCT02583672

COMPLETED NA

Safe and Effective Shoulder Exercise Training in Manual Wheelchair Users With SCI

NCT02777281

COMPLETED NA

Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia

NCT02482571

COMPLETED NA

Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways

NCT02529748

COMPLETED NA

Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome

NCT02470377

COMPLETED NA

Effects of Yoga on Parkinson's Disease

NCT02509611

COMPLETED NA

A Brief Appetite Awareness Intervention for Eating and Weight Regulation Among College Freshmen

NCT02496637

COMPLETED NA

Forearm Rotation Orthosis for Stroke

NCT01987414

COMPLETED NA

Mental Health eConsults

NCT02527915

COMPLETED

Predicting Rupture of AAA by Anatomic and Hemodynamic Markers

NCT02463760

TERMINATED Phase 2

The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

NCT02496780

COMPLETED NA

Mushroom Effects on Satiety and Gut Health Markers

NCT03352050

COMPLETED

Functional Connectivity Changes During Early Recovery as a Marker for Relapse

NCT02861820

COMPLETED Phase 1

A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis

NCT02464020

COMPLETED Phase 1

Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve Function

NCT02268448

COMPLETED NA

An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity

NCT02476032

COMPLETED Phase 2

PK/PD Study of U-500 Regular Insulin

NCT02148250

COMPLETED

Testing Native Language Neural Commitment at the Subcortical Level

NCT02774356

COMPLETED NA

Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications: A Randomized Controlled Trial

NCT02907892

COMPLETED Phase 1

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

NCT02191098

COMPLETED

DatScan With Prototype Collimator

NCT02455219

COMPLETED NA

Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDS

NCT02463773

COMPLETED NA

Methods Project 4: Clinical Trial - Amended

NCT03111537

COMPLETED

IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements

NCT02414490

COMPLETED NA

Testing a Community Intervention to Increase Aspirin Use

NCT02607917

COMPLETED Phase 1

A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

NCT02206152

COMPLETED NA

Satiety Effects of Pulses Compared to Matched Protein Smoothie

NCT02334540

COMPLETED NA

Novel Medication as a Potential Smoking Cessation Aid

NCT02265367

COMPLETED Phase 4

Enhancing Smoking Cessation in the Homeless Population

NCT01932996

COMPLETED NA

Brain Stimulation and Hand Training in Children With Hemiparesis

NCT02250092

COMPLETED NA

Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity

NCT02268461

COMPLETED NA

Ankle-foot Orthoses for Peripheral Artery Disease

NCT02280200

COMPLETED NA

Smoking Cessation in Menthol Flavored Cigarette Smokers

NCT02342327

COMPLETED Phase 2

Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

NCT02002819

COMPLETED NA

System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program

NCT02543190

COMPLETED Phase 2

The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease

NCT02252588

COMPLETED

Impact of the Minneapolis Staple Foods Ordinance

NCT02774330

COMPLETED NA

Finding an Optimal Latency for Paired Associative Stimulation in People With Chronic Stroke

NCT02188420

COMPLETED Phase 2

Ketamine in Adolescents With Treatment-Resistant Depression

NCT02078817

COMPLETED Phase 2

Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease

NCT02212678

COMPLETED Phase 2

Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

NCT01852942

TERMINATED

Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase

NCT02674945

COMPLETED Phase 2

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

NCT01972035

← Previous Page 13 of 20 Next →

Phase Distribution

PhaseTrial count
Phase 1 123
Phase 2 83
Phase 3 35
Phase 4 36

What is open in the University of Minnesota pipeline

180 recruiting of 966 indexed (19% open); 671 completed (69%).

Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).

Top condition: Obesity (14 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Minnesota: open-pipeline peers nationwide

Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share University of MinnesotaColumbia UniversityBrigham and Women's HospitalHoffmann-La RocheBristol-Myers SquibbUniversity of Alabama at BirminghamMclean HospitalChildren's Hospital Medical Center, CincinnatiArkansas Children's Hospital Research Institute
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 966 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Minnesota page

966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.

  • 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.